For many, the name Ozempic has become a buzzword for quick weight loss, the so-called “miracle shot” that’s all over TikTok ...

Novo Nordisk’s Wegovy faces sharp decline in growth forecasts and share value as competition intensifies and compounded drug ...

Last year saw a dramatic rise in employees prescribed these drugs, officials said, driving up costs for Erie County's largest public health insurance consortium by an estimated $7.8 million. That ...

Novo Nordisk downgraded to Buy amid guidance cuts & competition. Explore its long-term obesity drug potential, strong ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...

The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped significantly in the last few years, a new survey shows. The YouGov poll, ...

A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program ...

Three Motley Fool contributors believe they've found such unstoppable stocks with the "it" factor to buy in August -- and ...

The U.S. Food and Drug Administration on Wednesday approved Eli Lilly & Co.’s LLY obesity drug Zepbound, which in clinical trials helped patients lose up to 48 pounds on average. The drug was ...